317
Views
19
CrossRef citations to date
0
Altmetric
Review

Activity landscape of DNA methyltransferase inhibitors bridges chemoinformatics with epigenetic drug discovery

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Martin Vogt. (2018) Progress with modeling activity landscapes in drug discovery. Expert Opinion on Drug Discovery 13:7, pages 605-615.
Read now

Articles from other publishers (18)

Marzieh Ramezani Farani, Maryam Sarlak, Amir Gholami, Maryam Azaraian, Maryam Moradi Binabaj, Sareh Kakavandi, Murtaza M. Tambuwala, Afshin Taheriazam, Mehrdad Hashemi & Sorayya Ghasemi. (2023) Epigenetic drugs as new emerging therapeutics: What is the scale's orientation of application and challenges?. Pathology - Research and Practice 248, pages 154688.
Crossref
Marisa G. Santibáñez‐Morán & José L. Medina‐Franco. (2021) The Acid/Base Characterization of Molecules with Epigenetic Activity. ChemMedChem 16:11, pages 1745-1754.
Crossref
Fidele Ntie-Kang, Berin Karaman Mayack, Sergio Valente & Cecilia Battistelli. (2021) Editorial: Natural Product Epigenetic Modulators and Inhibitors. Frontiers in Pharmacology 12.
Crossref
Zoe Sessions, Norberto Sánchez-Cruz, Fernando D. Prieto-Martínez, Vinicius M. Alves, Hudson P. SantosJr.Jr., Eugene Muratov, Alexander Tropsha & José L. Medina-Franco. (2020) Recent progress on cheminformatics approaches to epigenetic drug discovery. Drug Discovery Today 25:12, pages 2268-2276.
Crossref
T.K. Shameera Ahamed & K. Muraleedharan. (2020) Towards a systematic analysis of structure-activity relationships of 5-LOX inhibitors through activity landscape and chemotype enrichment. Chemometrics and Intelligent Laboratory Systems 207, pages 104188.
Crossref
Wen Liu & Bing Luo. (2020) The impact of EBV on the epigenetics of gastric carcinoma. Future Virology 15:3, pages 183-193.
Crossref
Kenneth Lundstrom. (2019) Epigenetics, Nutrition, Disease and Drug Development. Current Drug Discovery Technologies 16:4, pages 386-391.
Crossref
Samuel Egieyeh, Sarel F. Malan & Alan Christoffels. (2019) Cheminformatics techniques in antimalarial drug discovery and development from natural products 1: basic concepts. Physical Sciences Reviews 4:7.
Crossref
J. Jesús Naveja, C. Iluhí Oviedo-Osornio, Nicole N. Trujillo-Minero & José L. Medina-Franco. (2017) Chemoinformatics: a perspective from an academic setting in Latin America. Molecular Diversity 22:1, pages 247-258.
Crossref
J. Jesús Naveja & José L. Medina-Franco. (2018) Insights from pharmacological similarity of epigenetic targets in epipolypharmacology. Drug Discovery Today 23:1, pages 141-150.
Crossref
J. Jesús Naveja, C. Iluhí Oviedo-Osornio & José L. Medina-Franco. 2018.
Mariana González-Medina, Oscar Méndez-Lucio & José L. Medina-Franco. (2017) Activity Landscape Plotter: A Web-Based Application for the Analysis of Structure–Activity Relationships. Journal of Chemical Information and Modeling 57:3, pages 397-402.
Crossref
Fernanda I. Saldívar-González, J. Jesús Naveja, Oscar Palomino-Hernández & José L. Medina-Franco. (2017) Getting SMARt in drug discovery: chemoinformatics approaches for mining structure–multiple activity relationships. RSC Advances 7:2, pages 632-641.
Crossref
Mario Omar García-Sánchez, Maykel Cruz-Monteagudo & José L. Medina-Franco. 2017. Advances in QSAR Modeling. Advances in QSAR Modeling 303 338 .
J. Jesús Naveja, Francisco Cortés-Benítez, Eugene Bratoeff & José L. Medina-Franco. (2016) Activity landscape analysis of novel 5$$\upalpha $$-reductase inhibitors. Molecular Diversity 20:3, pages 771-780.
Crossref
Petra Hudler. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 9 .
Eli Fernández-de Gortari & José L. Medina-Franco. (2015) Epigenetic relevant chemical space: a chemoinformatic characterization of inhibitors of DNA methyltransferases. RSC Advances 5:106, pages 87465-87476.
Crossref
J. Jesús Naveja & José L. Medina-Franco. (2015) Activity landscape sweeping: insights into the mechanism of inhibition and optimization of DNMT1 inhibitors. RSC Advances 5:78, pages 63882-63895.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.